OIA
ATRS

Optimum Investment Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Optimum Investment Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$3K – 957
2020
Q2 		$3K Hold
1,000
– – ﹤0.01% 805
2020
Q1 		$2K Sell
1,000
-7,000
-88% -$23.8K ﹤0.01% 827
2019
Q4 		$38K Buy
+8,000
New +$32.7K 0.01% 568

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Optimum Investment Advisors's ATRS Position: Q3 2020 in Review

Optimum Investment Advisors sold out of Antares Pharma, Inc. (ATRS) in Q3 2020, closing a stake of 1,000 shares — an estimated $3K sold.

Optimum Investment Advisors first reported a position in ATRS in Q4 2019 and held it in 3 quarters. The position peaked at $38K in Q4 2019. 164 funds tracked by Wall St. Rank hold ATRS as of Q3 2020.

  • Optimum Investment Advisors reported no remaining Antares Pharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Optimum Investment Advisors sold 1,000 Antares Pharma, Inc. shares in Q3 2020, an estimated $3K.
  • Optimum Investment Advisors first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 3 quarters.
  • Optimum Investment Advisors's Antares Pharma, Inc. position peaked at $38K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2020.

Based on Optimum Investment Advisors's 13F filing for Q3 2020, filed 6 Oct 2020.